Quick Answer
Cacao Flavanol Exercise Performance Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: While DC has been associated with various health benefits, its specific impact on endurance performance, particularly VO 2max , has not been conclusively established.
Key Takeaways
- 01While DC has been associated with various health benefits, its specific impact on endurance performance, particularly VO 2max , has not been conclusively established. [Mehdipour A (2025)]
- 02In conclusion, this meta-analysis suggests that DC consumption does not significantly improve VO 2max in healthy individuals. [Mehdipour A (2025)]
- 03The potential role of dark chocolate (DC) in enhancing exercise performance remains underexplored. [Mehdipour A (2025)]
- 04MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. [Tomaru Júlia Mayumi (2026)]
The current Migaku evidence database contains 2 reusable source documents for Cacao Flavanol Exercise Performance Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove.
- While DC has been associated with various health benefits, its specific impact on endurance performance, particularly VO 2max , has not been conclusively established. [Mehdipour A (2025); evidence level 1]
- In conclusion, this meta-analysis suggests that DC consumption does not significantly improve VO 2max in healthy individuals. [Mehdipour A (2025); evidence level 1]
- The potential role of dark chocolate (DC) in enhancing exercise performance remains underexplored. [Mehdipour A (2025); evidence level 1]
- MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. [Tomaru Júlia Mayumi (2026); evidence level 3]
- It is possible to develop a close relationship with MetS, metabolic dysfunction-associated steatotic liver disease (MASLD), and CVD [,]. [Tomaru Júlia Mayumi (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources